Filter
3639
Filtered Results: 3639
Text search:
drug
supply
Featured
Recommendations
348
New Publications
1098
Language
Document type
No document type
2206
Studies & Reports
535
Guidelines
485
Manuals
164
Strategic & Response Plan
128
Training Material
46
Fact sheets
42
Situation Updates
17
Infographics
7
Resource Platforms
5
Brochures
2
App
1
Online Courses
1
Countries / Regions
India
248
Kenya
116
Global
108
Ethiopia
106
Uganda
101
South Africa
89
Nigeria
81
Tanzania
76
Western and Central Europe
75
Nepal
71
Malawi
69
Sierra Leone
68
Liberia
66
Myanmar / Burma
60
Zambia
58
Ghana
55
Bangladesh
53
Africa
46
Rwanda
37
Ukraine
36
Eastern Europe
36
Philippines
34
Namibia
34
Zimbabwe
32
Latin America and the Carribbean
32
Asia
29
Cambodia
28
Lesotho
26
Russia
26
South–East Asia Region
25
Botswana
22
Syria
20
Indonesia
20
Senegal
16
Mozambique
15
Congo, Democratic Republic of
15
Burkina Faso
14
East and Southern Africa
13
Middle East and North Africa
11
South Sudan
11
Eswatini/ Swaziland
11
Germany
10
Eastern Europe and Central Asia
10
Brazil
10
Georgia
10
Cameroon
9
Haiti
9
West and Central Africa
9
Albania
8
Venezuela
8
Pakistan
8
Tajikistan
7
Colombia
7
Thailand
7
Guinea
7
Vietnam
7
Sudan
7
Afghanistan
6
Western Pacific Region
6
North Macedonia
5
Benin
5
Laos
5
USA
5
Moldova
5
Argentina
4
Lebanon
4
Sri Lanka
4
Yemen
4
Iraq
4
Timor Leste/ East Timor
3
Turkey
3
China
3
Kyrgyzstan
3
Peru
3
Armenia
3
Jordan
3
Paraguay
3
North America
3
Jamaica
3
United Kingdom
3
Bhutan
3
Madagascar
3
Mexico
2
Canada
2
Fiji
2
Estonia
2
Morocco
2
Hungary
2
Saudi Arabia
2
Portugal
2
Papua New Guinea
2
Central African Republic
2
Poland
2
Angola
2
Libya
2
Somalia
2
North Korea
1
El Salvador
1
Serbia
1
Australia
1
Gambia
1
Kazakhstan
1
Chile
1
Iran
1
Singapore
1
Uzbekistan
1
Bulgaria
1
Guinea-Bissau
1
Gabon
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Tunisia
1
Norway
1
Spain
1
Belarus
1
Bolivia
1
Greece
1
Palestine
1
Honduras
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
1582
Clinical Guidelines
330
Public Health
171
Women & Child Health
140
Key Resources
122
Pharmacy & Technologies
61
Capacity Building
46
Annual Report MEDBOX
1
Toolboxes
HIV
385
TB
325
Mental Health
230
AMR
183
COVID-19
175
Pharmacy
149
NTDs
141
Caregiver
80
NCDs
69
Rapid Response
59
Ebola & Marburg
56
Planetary Health
53
Conflict
52
Global Health Education
37
Refugee
33
Health Financing Toolbox
24
Disability
23
Natural Hazards
17
Polio
17
Cholera
15
Specific Hazards
12
Malaria
11
Social Ethics
7
Zika
6
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s...
The Libyan national action plan has been aligned with WHO five objectives. Analysis of the current situation and addressing the gaps and the needs to reach the main goal “one health” approach involves several national sectors and actors, including human and veterinary health, agriculture and foo...
Non-Wood Forest Products 11
Traditional medicine and its use of medicinal plants is dependent on reliable supply of plant materials. The book focuses on the interface between medicinal plant use and conservation of medicinal plants.
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resistance and lead to loss of confidence in health prof...
The purpose of this manual is to define a limited number of indicators that will objectively describe the management and use of antimicrobials in hospitals and to provide tools and step-by-step instructions for designing and carrying out an assessment of antibiotic use and management in hospitals. T...
Vreeman RC et al. Journal of the International AIDS Society 2017, 20(Suppl 3):21497 http://www.jiasociety.org/index.php/jias/article/view/21497 | http://dx.doi.org/10.7448/IAS.20.4.21497
We systematically reviewed Medline as well as the references of published review articles for relevant studies of adherence to multidrug treatment of both drug-susceptible and drug-resistant TB through February 3, 2018. We included randomized controlled trials (RCTs) as well as prospective and retro...
Ann Indian Acad Neurol. 2015 Sep; 18(Suppl 1): S2–S5.
doi: 10.4103/0972-2327.164812
PMCID: PMC4604693
PMID: 26538844
Mohamed et al. BMC Public Health 2018, 18(Suppl 3):1215
https://doi.org/10.1186/s12889-018-6053-xpre-
Translation of the 1st ed., 2003
These guidelines were written for anyone trying to meet and solve the challenges of operating a warehouse today. They are an important reference tool for managers and staff, whether they are constructing a new warehouse, implementing a new warehouse syste...
These guidelines were written for anyone trying to meet and solve the challenges of operating a warehouse today. They are an important reference tool for managers and staff, whether they are constructing a new warehouse, implementing a new warehouse syste...
Co-trimoxazole is a fixed-dose combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections. Co-trimoxazole preventive therapy is a feasible, well tolerated and inexpensive intervention for people living with HIV to re...
This document provides guidance on how to implement contact screening and chemoprophylaxis with single-dose rifampicin. The contents are logically ordered: counselling and obtaining consent, identification and listing of index case, listing of contacts, tracing of contacts, screening of contacts, ad...
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been developed and forms part of the Five Year National Strateg...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti...
An Act to repeal the Dangerous Medicines Act of 1973,to ensure the availability of certain drugs for exclusive medical, scientific and related purposes, while preventing their abuse; to prevent the diversion from lawful trade of controlled chemicals, controlled equipment and controlled materials for...
The main objective of these guidelines is to provide guidance on up-to-date, uniform, evidence-informed practices for suspecting, diagnosing and managing various forms of extra-pulmonary tuberculosis (EPTB) at all levels of healthcare delivery. They can then contribute to the National Programme to i...
Antimicrobials have been a critical public health tool since the discovery of penicillin in 1928, saving the lives of millions of people around the world. Today, however, the emergence of drug resistance is reversing the miracles of the past eighty years, with drug choices for the treatment of many ...
Submitted to the US Agency for International Development by the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program. Arlington, VA: Management Sciences for Health. Submitted to the United Nations Children’s Fund by JSI, Arlington, VA: JSI Research & Training Institute, Inc....
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
recommended
The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of n...
